Forward genetic dissection of innate response to infection in inbred mouse strains: Selected success stories

Clinical and Experimental Immunology

Volumn 162, Issue 3, 2010, Pages 393-401

  Gruenheid, S ^a   Gros, P ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Host resistance; Infection; Innate immunity; Mouse genetics

Indexed keywords

CD14 ANTIGEN; CD36 ANTIGEN; ETHYLNITROSOUREA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; OSTEOPONTIN; STAT1 PROTEIN; TOLL LIKE RECEPTOR; CYTOKINE; PATTERN RECOGNITION RECEPTOR;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHRONIC MYELOID LEUKEMIA; GENE MUTATION; HUMAN; INNATE IMMUNITY; LEGIONELLA PNEUMOPHILA; LEISHMANIA DONOVANI; LUNG TUBERCULOSIS; MOUSE; NONHUMAN; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; TH1 CELL; ANIMAL; BACTERIAL INFECTION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MOUSE STRAIN; REVIEW; VIRUS INFECTION;

ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; MICE, INBRED STRAINS; POLYMORPHISM, GENETIC; RECEPTORS, PATTERN RECOGNITION; VIRUS DISEASES;

EID: 79952462230     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04249.x     Document Type: Article

References (97)

1. Min-Oo G, Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol 2005; 7:753-63.
2. Lederman MM, Penn-Nicholson A, Cho M, Mosier D. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006; 296:815-26.
3. Kwiatkowski DP. How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 2005; 77:171-92.
4. Fischer A. Human primary immunodeficiency diseases. Immunity 2007; 27:835-45.
5. Hill AV. Aspects of genetic susceptibility to human infectious diseases. Annu Rev Genet 2006; 40:469-86.
6. Casanova JL, Abel L. Human genetics of infectious diseases: a unified theory. EMBO J 2007; 26:915-22.
7. Vidal SM, Malo D, Marquis JF, Gros P. Forward genetic dissection of immunity to infection in the mouse. Annu Rev Immunol 2008; 26:81-132.
8. Peters LL, Robledo RF, Bult CJ, Churchill GA, Paigen BJ, Svenson KL. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev Genet 2007; 8:58-69.
9. Hoyne GF, Goodnow CC. The use of genomewide ENU mutagenesis screens to unravel complex mammalian traits: identifying genes that regulate organ-specific and systemic autoimmunity. Immunol Rev 2006; 210: 27-39.
10. Hoebe K, Beutler B. Unraveling innate immunity using large scale N-ethyl-N-nitrosourea mutagenesis. Tissue Antigens 2005; 65: 395-401.
11. Kumar H, Kawai T, Akira S. Toll-like receptors and innate immunity. Biochem Biophys Res Commun 2009; 388: 621-5.
12. Franchi L, Warner N, Viani K, Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 2009; 227: 106-28.
13. Sultzer BM. Genetic control of leucocyte responses to endotoxin. Nature 1968; 219: 1253-4.
14. Robson HG, Vas SI. Resistance of inbred mice to Salmonella typhimurium. J Infect Dis 1972; 126: 378-86.
15. Watson J, Riblet R, Taylor BA. The response of recombinant inbred strains of mice to bacterial lipopolysaccharides. J Immunol 1977; 118: 2088-93.
16. Poltorak A, Smirnova I, He X et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998; 24: 340-55.
17. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-8.
18. Qureshi ST, Lariviere L, Leveque G et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 1999; 189: 615-25.
19. Hoebe K, Du X, Georgel P et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743-8.
20. Hoebe K, Georgel P, Rutschmann S et al.CD36 is a sensor of diacylglycerides. Nature 2005; 433: 523-7.
21. Jiang Z, Georgel P, Du X et al. CD14 is required for MyD88-independent LPS signaling. Nat Immunol 2005; 6: 565-70.
22. Tabeta K, Hoebe K, Janssen EM et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol 2006; 7: 156-64.
23. Kim YM, Brinkmann MM, Paquet ME, Ploegh HL. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008; 452: 234-8.
24. Bousfiha A, Picard C, Boisson-Dupuis S et al. Primary immunodeficiencies of protective immunity to primary infections. Clin Immunol 2010; 135: 204-9.
25. Dietrich WF, Damron DM, Isberg RR, Lander ES, Swanson MS. Lgn1, a gene that determines susceptibility to Legionella pneumophila, maps to mouse chromosome 13. Genomics 1995; 26: 443-50.
26. Beckers MC, Yoshida S, Morgan K, Skamene E, Gros P. Natural resistance to infection with Legionella pneumophila: chromosomal localization of the Lgn1 susceptibility gene. Mamm Genome 1995; 6: 540-5.
27. Scharf JM, Damron D, Frisella A et al. The mouse region syntenic for human spinal muscular atrophy lies within the Lgn1 critical interval and contains multiple copies of Naip exon 5. Genomics 1996; 38: 405-17.
28. Diez E, Lee SH, Gauthier S et al. Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat Genet 2003; 33: 55-60.
29. Wright EK, Goodart SA, Growney JD et al. Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr Biol 2003; 13: 27-36.
30. Inohara N, Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 2001; 20:6473-81.
31. Girardin SE, Sansonetti PJ, Philpott DJ. Intracellular vs extracellular recognition of pathogens - common concepts in mammals and flies. Trends Microbiol 2002; 10: 193-9.
32. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2006; 2: e18.
33. Zamboni DS, Kobayashi KS, Kohlsdorf T et al. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat Immunol 2006; 7: 318-25.
34. Boyden ED, Dietrich WF. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 2006; 38: 240-4.
35. Nour AM, Yeung YG, Santambrogio L, Boyden ED, Stanley ER, Brojatsch J. Anthrax lethal toxin triggers the formation of a membrane-associated inflammasome complex in murine macrophages. Infect Immun 2009; 77: 1262-71.
36. Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 2009; 4: 365-98.
37. Schurr E, Gros P. A common genetic fingerprint in leprosy and Crohn's disease? N Engl J Med 2009; 361: 2666-8.
38. Zhang FR, Huang W, Chen SM et al. Genomewide association study of leprosy. N Engl J Med 2009; 361: 2609-18.
39. Pyzik M, Kielczewska A, Vidal SM. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Semin Immunol 2008; 20: 331-42.
40. Grundy JE, Mackenzie JS, Stanley NF. Influence of H-2 and non-H-2 genes on resistance to murine cytomegalovirus infection. Infect Immun 1981; 32: 277-86.
41. Chalmer JE, Mackenzie JS, Stanley NF. Resistance to murine cytomegalovirus linked to the major histocompatibility complex of the mouse. J Gen Virol 1977; 37: 107-14.
42. Depatie C, Muise E, Lepage P, Gros P, Vidal SM. High-resolution linkage map in the proximity of the host resistance locus Cmv1. Genomics 1997; 39: 154-63.
43. Forbes CA, Brown MG, Cho R, Shellam GR, Yokoyama WM, Scalzo AA. The Cmv1 host resistance locus is closely linked to the Ly49 multigene family within the natural killer cell gene complex on mouse chromosome 6. Genomics 1997; 41: 406-13.
44. Lee SH, Girard S, Macina D et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001; 28: 42-5.
45. Smith HR, Heusel JW, Mehta IK et al. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 2002; 99: 8826-31.
46. Desrosiers MP, Kielczewska A, Loredo-Osti JC et al. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat Genet 2005; 37: 593-9.
47. Adam SG, Caraux A, Fodil-Cornu N et al. Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice. J Immunol 2006; 176: 5478-85.
48. Beutler B. Mutagenetix: a database of mutations identified in the Beutler Laboratory at The Scripps Research Institute. La Jolla, CA: Department of Genetics, The Scripps Research Institute, 2010.
49. Biassoni R, Ugolotti E, De Maria A. NK cell receptors and their interactions with MHC. Curr Pharm Des 2009; 15: 3301-10.
50. Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCGosis and tuberculosis. Annu Rev Genomics Hum Genet 2007; 8: 163-92.
51. Turcotte K, Gauthier S, Malo D, Tam M, Stevenson MM, Gros P. Icsbp1/IRF-8 is required for innate and adaptive immune responses against intracellular pathogens. J Immunol 2007; 179: 2467-76.
52. Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, Gros P. A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med 2005; 201:881-90.
53. Turcotte K, Gauthier S, Mitsos LM et al. Genetic control of myeloproliferation in BXH-2 mice. Blood 2004; 103: 2343-50.
54. Aliberti J, Schulz O, Pennington DJ et al. Essential role for ICSBP in the in vivo development of murine CD8alpha + dendritic cells. Blood 2003; 101: 305-10.
55. Pan H, Yan BS, Rojas M et al. Ipr1 gene mediates innate immunity to tuberculosis. Nature 2005; 434: 767-72.
56. Roscioli T, Cliffe ST, Bloch DB et al. Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet 2006; 38: 620-2.
57. Tosh K, Campbell SJ, Fielding K et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci USA 2006; 103: 10364-8.
58. Babb C, Keet EH, van Helden PD, Hoal EG. SP110 polymorphisms are not associated with pulmonary tuberculosis in a South African population. Hum Genet 2007; 121: 521-2.
59. Thye T, Browne EN, Chinbuah MA et al. No associations of human pulmonary tuberculosis with Sp110 variants. J Med Genet 2006; 43: e32.
60. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986; 83: 8819-23.
61. Patarca R, Freeman GJ, Singh RP et al. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 1989; 170: 145-61.
62. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009; 3: 311-22.
63. Rittling SR, Zetterberg C, Yagiz K et al. Protectiveroleofosteopontin in endodontic infection. Immunology 2009.
64. Maeno Y, Shinzato M, Nagashima S et al. Effect of osteopontin on diarrhea duration and innate immunity in suckling mice infected with a murine rotavirus. Viral Immunol 2009; 22: 139-44.
65. Maeno Y, Nakazawa S, Yamamoto N et al. Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice. Infect Immun 2006; 74: 2423-7.
66. Rollo EE, Hempson SJ, Bansal A et al. The cytokine osteopontin modulates the severity of rotavirus diarrhea. J Virol 2005; 79: 3509-16.
67. Ashkar S, Weber GF, Panoutsakopoulou V et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287: 860-4.
68. Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 1999; 67: 4223-30.
69. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73: 469-85.
70. Vidal SM, Pinner E, Lepage P, Gauthier S, Gros P. Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol 1996; 157: 3559-68.
71. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular pathogens: the Nramp1 protein is 400 recruited to the membrane of the phagosome. J Exp Med 1997; 185: 717-30.
72. Forbes JR, Gros P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 2003; 102: 1884-92.
73. Jabado N, Jankowski A, Dougaparsad S, Picard V, Grinstein S, Gros P. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J Exp Med 2000; 192: 1237-48.
74. Hackam DJ, Rotstein OD, Zhang W, Gruenheid S, Gros P, Grinstein S. Host resistance to intracellular infection: mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification. J Exp Med 1998; 188: 351-64.
75. Frehel C, Canonne-Hergaux F, Gros P, De Chastellier C. Effect of Nramp1 on bacterial replication and on maturation of Mycobacterium avium-containing phagosomes in bone marrow-derived mouse macrophages. Cell Microbiol 2002; 4: 541-56.
76. Cuellar-Mata P, Jabado N, Liu J et al. Nramp1 modifies the fusion of Salmonella typhimurium-containing vacuoles with cellular endomembranes in macrophages. J Biol Chem 2002; 277: 2258-65.
77. Huynh C, Sacks DL, Andrews NW. A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes. J Exp Med 2006; 203: 2363-75.
78. Fortier A, de Chastellier C, Balor S, Gros P. Birc1e/Naip5 rapidly antagonizes modulation of phagosome maturation by Legionella pneumophila. Cell Microbiol 2007; 9: 910-23.
79. Fortier A, Doiron K, Saleh M, Grinstein S, Gros P. Restriction of Legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators Irf1 and Irf8 and nod-like receptors Naip5 and Nlrc4. Infect Immun 2009; 77: 4794-805.
80. Carabeo RA, Mead DJ, Hackstadt T. Golgi-dependent transport of cholesterol to the Chlamydia trachomatis inclusion. Proc Natl Acad Sci USA 2003; 100: 6771-6.
81. Bernstein-Hanley I, Balsara ZR, Ulmer W, Coers J, Starnbach MN, Dietrich WF. Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun 2006; 7: 122-9.
82. Bernstein-Hanley I, Coers J, Balsara ZR, Taylor GA, Starnbach MN, Dietrich WF. The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci USA 2006; 103: 14092-7.
83. Tietzel I, El-Haibi C, Carabeo RA. Human guanylate binding Mouse genetics and innate immunity proteins potentiate the anti-chlamydia effects of interferon-gamma. PLoS One 2009; 4: e6499.
84. Fortin A, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria in mice. Genes Immun 2002; 3: 177-86.
85. Min-Oo G, Fortin A, Pitari G, Tam M, Stevenson MM, Gros P. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med 2007; 204: 511-24.
86. Min-Oo G, Ayi K, Tam M et al. Cysteamine as a novel anti-malarial drug. Exp Parasitol 2010; in press.
87. Min-Oo G, Ayi K, Bongfen SE et al. Cysteamine, the natural metabolite of pantetheinase, shows specific activity against Plasmodium. Exp Parasitol 2010; 125: 315-24.
88. Haller O, Arnheiter H, Gresser I, Lindenmann J. Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 1979; 149: 601-12.
89. Horisberger MA, Staeheli P, Haller O. Interferon induces a unique protein in mouse cells bearing a gene for resistance to influenza virus. Proc Natl Acad Sci USA 1983; 80: 1910-14.
90. Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol Cell Biol 1988; 8: 4518-23.
91. Zurcher T, Pavlovic J, Staeheli P. Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology 1992; 187: 796-800.
92. Haller O, Kochs G. Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002; 3: 710-17.
93. Mashimo T, Lucas M, Simon-Chazottes D et al. Anonsensemutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci USA 2002; 99: 11311-16.
94. Perelygin AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA. Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci USA 2002; 99: 9322-7.
95. Samuel MA, Diamond MS. Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 2006; 80: 9349-60.
96. Bonnevie-Nielsen V, Larsen ML, Frifelt JJ, Michelsen B, Lernmark A. Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. Diabetes 1989; 38: 1636-42.
97. Bonnevie-Nielsen V, Field LL, Lu S et al. Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS)enzymeactivityiscontrolled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene. Am J Hum Genet 2005; 76: 623-33.